Table 2.

Estimated 5- and 10-year survival rates for patients with vertical growth phase melanoma (product-limit method) using death from melanoma as end point

VariablesNo. casesEstimated survival rates (%)
P*
5 y10 y
E-cadherin expression
    Weak7662490.594
    Strong576154
N-cadherin expression
    Weak8864570.174
    Strong405740
P-cadherin expression
    Weak3776620.047
    Strong855346
β-catenin expression§
    Absent8955400.0072
    Present447672
Wnt5a§
    Weak6657420.23
    Strong606559
Frizzled§
    Weak7460550.66
    Strong525947
  • * Log-rank test.

  • Membranous expression.

  • Cytoplasmic expression.

  • § Nuclear expression.